Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients

22 Jul 2023

Abstract excerpt

BACKGROUND: Prolyl 4-hydroxylase subunit beta (P4HB) has been reported as a suppressor in ferroptosis. However, no known empirical research has focused on exploring relationships between P4HB and prostate cancer (PCa). In this research, we initially examine the function of P4HB in PCa by thorough analysis of numerous databases and proliferation experiment. METHODS: We analyzed the correlations of P4HB expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37480146
DOI: 10.1186/s40001-023-01215-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patientsPMID 37480146Read ↗

Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or RadiotherapySemantic proximity Read ↗

Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate CancerSemantic proximity Read ↗

Identification and validation of a ferroptosis-related genes based prognostic signature for prostate cancerSemantic proximity Read ↗

Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glanceSemantic proximity Read ↗

The distinct role of ALDH1A1 and ALDH1A3 in the regulation of prostate cancer metastasesSemantic proximity Read ↗

Identification of senescence-related molecular subtypes and key genes for prostate cancerSemantic proximity Read ↗

Identification of Ferroptosis-Associated Genes in Prostate Cancer by Bioinformatics AnalysisSemantic proximity Read ↗

Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanismSemantic proximity Read ↗

Single-cell analysis extracted CAFs-related genes to established online app to predict clinical outcome and radiotherapy prognosis of prostate cancerSemantic proximity Read ↗

Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate CancerSemantic proximity Read ↗

Integrated analysis of single‑cell and bulk RNA‑sequencing identifies a signature based on macrophage marker genes involved in prostate cancer prognosis and treatment responsivenessSemantic proximity Read ↗

A gene feature based on histone modifications can predict the prognosis of prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.